Friday, February 20, 2026
19.4 C
Bengaluru

Is Pharma Losing Good SalesPeople

MedicinMan October 2015

[wpfilebase tag=file id=54 tpl=download-button /]

Inside this Issue

1. L&D Sans Time and Space Constraints by Gopal Kishore

How technology is making time and space irrelevant to learning and development.

2. Book Review: Your Strategy Needs a Strategy by K. Hariram

“How to Choose and Execute the right approach”

3. Patient Access Part-II: Patient Journey Mapping (PJM) by Pankaj Mehrotra

PJM gives life science companies insight into each stage of the patient journey from awareness of the condition to treatment adherence and lifestyle change.

4. Brand Audit and SWOT Analysis – A Tool for Brand Managers by Vivek Hattangadi

How to use the powerful SWOT to gauge the health of a brand.

5. Four Questions Every Training Dept. Should Ask Itself by Hanno Wolfram

In order for training programs to have a measurable impact on business, the training department needs to answer four important questions.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img